Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Cecilia Larocca, M.D.

Title
Institution
Department
Address

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
Displaying 25 of 30 total Publications Show all
  1. Zhang AJ, Ball G, Zundell MP, Agüero R, Yee D, Shields A, Asare C, Navrazhina K, Liu W, Foolad N, Kwock J, Tejwani P, Hamade H, Jaleel T, Butler D, Silverberg N, Nattkemper L, Siegel DM, Tan J, Kim BS, Larocca C, Shinohara MM, Ehlert A, Latella J, Guttman-Yassky E, Krueger JG, Strand V, Armstrong AW, Merola JF, Perez-Chada L, Gottlieb AB. International Dermatology Outcome Measures (IDEOM): A Report From the 2023 Annual Meeting. J Drugs Dermatol. 2024 Dec 01; 23(12):1114-1120. PMID: 39630678.
    Citations:
    Fields: DerDermatologyTranslation:Humans
  2. Apalla Z, Freites-Martinez A, Grafanaki K, Ortiz-Brugues A, Nikolaou V, Fattore D, Sollena P, Deverapalli S, Babakoohi S, Galimont A, Kluger N, Beylot-Barry M, Larocca C, Iriarte C, Smith J, Tattersall I, Dodiuk-Gad R, Sauder M, Carrera C, Kwong B, Whitley M, Leboeuf N, Romano P, Starace M, Mateeva V, Riganti J, Hirner J, Patel AB, Reyes-Habito CM, Kraehenbuehl L, Kheterpal M, Fida M, Hassel J, Lacouture M, Sibaud V. Management of human epidermal growth factor receptor inhibitors-related acneiform rash: A position paper based on the first Europe/USA Delphi consensus process. J Eur Acad Dermatol Venereol. 2024 Oct 26. PMID: 39460590.
    Citations:
    Fields: DerDermatologySexSexually Transmitted Diseases
  3. Brazel D, Larocca C, Shinohara MM. Assessing Health-Related Quality of Life in Mycosis Fungoides and Sézary Syndrome: Unmet Needs. Cancers (Basel). 2024 Aug 03; 16(15). PMID: 39123484; PMCID: PMC11312166.
    Citations:
  4. Chen ST, Semenov YR, Alloo A, Bach DQ, Betof Warner A, Bougrine A, Burton L, Cappelli LC, Castells M, Cohen J, Dewan AK, Fadden R, Guggina L, Hegde A, Huang V, Johnson DB, Kaffenberger B, Kroshinsky D, Kwatra S, Kwong B, Lacouture ME, Larocca C, Leventhal J, Markova A, McDunn J, Mooradian MJ, Naidoo J, Choi J, Nambudiri V, Nelson CA, Patel AB, Pimkina J, Rine J, Rubin KM, Sauder M, Shaigany S, Shariff A, Sullivan RJ, Zubiri L, Reynolds KL, LeBoeuf NR. Defining D-irAEs: consensus-based disease definitions for the diagnosis of dermatologic adverse events from immune checkpoint inhibitor therapy. J Immunother Cancer. 2024 Apr 10; 12(4). PMID: 38599660; PMCID: PMC11015215.
    Citations: 2
    Fields: NeoNeoplasmsTheTherapeuticsTranslation:Humans
  5. Kim EY, Awh KC, Larocca CA. Everolimus-induced Symmetrical Drug-related Intertriginous and Flexural Exanthema. Acta Derm Venereol. 2023 12 19; 103:adv12197. PMID: 38112207; PMCID: PMC10753590.
    Citations:
    Fields: DerDermatologySexSexually Transmitted DiseasesTranslation:Humans
  6. Lee K, Woodbury MJ, Zundell MP, Aguero R, Yousif J, Williams SC, Rosmarin D, Silverberg N, Thiboutot D, Larocca C, Shinohara MM, Mostaghimi A, Stander S, Martorell A, Jaleel T, Torbeck RL, Siegel DM, Perez-Chada L, Strand V, Armstrong AW, Merola JF, Gottlieb AB. International Dermatology Outcome Measures (IDEOM) - Report from the 2022 Annual Meeting. J Drugs Dermatol. 2023 Dec 01; 22(12):1153-1159. PMID: 38051841.
    Citations:
    Fields: DerDermatologyTranslation:Humans
  7. Larocca CA, Fay CJ, Hirner JP, Meyerhardt JA, Cleary JM, Dewan AK, LeBoeuf NR. Diffuse Cutaneous Aphthosis After Combined Targeted Cancer Therapies and Responsive to Pentoxifylline. JAMA Dermatol. 2023 10 01; 159(10):1136-1139. PMID: 37610794; PMCID: PMC10448362.
    Citations:
    Fields: DerDermatologyTranslation:Humans
  8. Yu Z, Vieyra-Garcia P, Benezeder T, Crouch JD, Kim IR, O'Malley JT, Devlin PM, Gehad A, Zhan Q, Gudjonsson JE, Sarkar MK, Kahlenberg JM, Gerard N, Teague JE, Kupper TS, LeBoeuf NR, Larocca C, Tawa M, Pomahac B, Talbot SG, Orgill DP, Wolf P, Clark RA. Phototherapy Restores Deficient Type I IFN Production and Enhances Antitumor Responses in Mycosis Fungoides. J Invest Dermatol. 2024 Mar; 144(3):621-632.e1. PMID: 37716650; PMCID: PMC10922223.
    Citations: 1
    Fields: DerDermatologyTranslation:HumansCells
  9. Said JT, Iriarte C, Talia J, Leung B, Virgen CA, Robertson M, Rabin MS, Larocca C, LeBoeuf NR. Pembrolizumab-associated expansion of radiation-induced morphoea responsive to dupilumab: a case report. Clin Exp Dermatol. 2023 08 25; 48(9):1077-1080. PMID: 37119266.
    Citations: 1
    Fields: DerDermatologyTranslation:Humans
  10. Virgen CA, Sparks JA, Nohria A, O'Hare MJ, Goyal A, Said JT, Tawa M, LeBoeuf NR, Kupper TS, Fisher DC, Larocca C. Mogamulizumab-Associated Myositis With and Without Myasthenia Gravis and/or Myocarditis in Patients With T-Cell Lymphoma. Oncologist. 2023 08 03; 28(8):e694-e698. PMID: 37285523; PMCID: PMC10400128.
    Citations:
    Fields: NeoNeoplasmsTranslation:Humans
  11. Fay CJ, Jakuboski S, Mclellan B, Allais BS, Semenov Y, Larocca CA, LeBoeuf NR. Diagnosis and Management of Dermatologic Adverse Events from Systemic Melanoma Therapies. Am J Clin Dermatol. 2023 Sep; 24(5):765-785. PMID: 37395930; PMCID: PMC10796164.
    Citations: 1
    Fields: DerDermatologyTranslation:Humans
  12. Jfri A, Virgen CA, Tawa M, Giobbie-Hurder A, Kupper TS, Fisher DC, LeBoeuf NR, Larocca C. Prevalence and implications of mogamulizumab-induced immune-related adverse events in mycosis fungoides/Sézary syndrome; a single-center experience. J Am Acad Dermatol. 2023 Nov; 89(5):1044-1047. PMID: 37321484.
    Citations: 2
    Fields: DerDermatology
  13. Gupta N, Virgen CA, Goyal A, Lane AA, Antin JH, Divito SJ, Larocca C. Novel use of acitretin for posttransplant Grover's disease and cutaneous graft versus host disease. JAAD Case Rep. 2023 Mar; 33:67-69. PMID: 36890866; PMCID: PMC9988423.
    Citations:
  14. Fay CJ, Awh KC, LeBoeuf NR, Larocca CA. Harnessing the immune system in the treatment of cutaneous T cell lymphomas. Front Oncol. 2022; 12:1071171. PMID: 36713518; PMCID: PMC9878398.
    Citations: 1
  15. Jfri A, Smith JS, Larocca C. Diagnosis of mycosis fungoides or Sézary syndrome after dupilumab use: A systematic review. J Am Acad Dermatol. 2023 05; 88(5):1164-1166. PMID: 36481378.
    Citations: 6
    Fields: DerDermatologyTranslation:Humans
  16. Yeh JE, Lorenzo ME, Larocca C, Fisher DC, Foreman RK. Small lymphocytic lymphoma presenting as chronic diffuse lip swelling. Dermatol Online J. 2022 Oct 15; 28(5). PMID: 36809138.
    Citations:
    Fields: DerDermatologyTranslation:Humans
  17. Zagona-Prizio C, Yousif J, Grant C, Mehta M, Rosmarin D, Silverberg N, Tan J, Larocca C, Shinohara M, Mostaghimi A, Kim B, Gulliver S, Gulliver W, Siegel D, Perez-Chada L, Merola J, Gottlieb A, Armstrong A. International Dermatology Outcome Measures (IDEOM): Report from the 2021 Annual Meeting. J Drugs Dermatol. 2022 Aug 01; 21(8):867-874. PMID: 35946973.
    Citations: 2
    Fields: DerDermatologyTranslation:Humans
  18. Plumptre IR, Said JT, Sun T, Larocca C, Virgen CA, Kupper TS, Fisher DC, Devlin PM, Elco CP, Song JS, LeBoeuf NR. Clinical features and treatment outcomes for primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder: a retrospective cohort study from the Dana-Farber Cancer Institute and updated literature review. Leuk Lymphoma. 2022 12; 63(12):2832-2846. PMID: 35862569.
    Citations: 1
    Fields: HemHematologyNeoNeoplasmsTranslation:HumansCells
  19. Larocca C, Shanmugam V, Zemmour D, Antin JH, Lane AA. Shared Clonal Origin of Multiple Histiocytic and Dendritic Neoplasms and Polycythemia Vera, Follicular Lymphoma in 1 Patient. Am J Dermatopathol. 2022 12 01; 44(12):929-932. PMID: 35642960.
    Citations:
    Fields: DerDermatologyPatPathologyTranslation:HumansCells
  20. Yu KK, Smith NP, Essien SV, Teague JE, Vieyra-Garcia P, Gehad A, Zhan Q, Crouch JD, Gerard N, Larocca C, Wolf P, LeBoeuf NR, Tawa M, Kupper TS, Villani AC, Clark RA. IL-32 Supports the Survival of Malignant T Cells in Cutaneous T-cell Lymphoma. J Invest Dermatol. 2022 08; 142(8):2285-2288.e2. PMID: 35143819; PMCID: PMC9329172.
    Citations: 3
    Fields: DerDermatologyTranslation:HumansCells
  21. Bui AN, Larocca C, Giobbie-Hurder A, Jacobsen ED, LeBoeuf NR. Cutaneous Langerhans cell histiocytosis in adults: A retrospective cohort study of adult patients presenting to a single academic cancer center between 2003 and 2017. J Am Acad Dermatol. 2022 06; 86(6):1413-1416. PMID: 34119604.
    Citations:
    Fields: DerDermatologyTranslation:Humans
  22. Larocca CA, LeBoeuf NR, Silk AW, Kaufman HL. An Update on the Role of Talimogene Laherparepvec (T-VEC) in the Treatment of Melanoma: Best Practices and Future Directions. Am J Clin Dermatol. 2020 Dec; 21(6):821-832. PMID: 32767272.
    Citations: 15
    Fields: DerDermatologyTranslation:HumansCells
  23. Bui AN, Singer S, Hirner J, Cunningham-Bussel AC, Larocca C, Merola JF, Lian CG, LeBoeuf NR. De novo cutaneous connective tissue disease temporally associated with immune checkpoint inhibitor therapy: A retrospective analysis. J Am Acad Dermatol. 2021 Mar; 84(3):864-869. PMID: 33323344.
    Citations: 7
    Fields: DerDermatologyTranslation:Humans
  24. Bui AN, Hirner J, Singer SB, Eberly-Puleo A, Larocca C, Lian CG, LeBoeuf NR. De novo subacute cutaneous lupus erythematosus-like eruptions in the setting of programmed death-1 or programmed death ligand-1 inhibitor therapy: clinicopathological correlation. Clin Exp Dermatol. 2021 Mar; 46(2):328-337. PMID: 32939795.
    Citations: 9
    Fields: DerDermatologyTranslation:Humans
  25. O'Malley JT, de Masson A, Lowry EL, Giobbie-Hurder A, LeBoeuf NR, Larocca C, Gehad A, Seger E, Teague JE, Fisher DC, Kupper TS, Devlin PM, Clark RA. Radiotherapy Eradicates Malignant T Cells and Is Associated with Improved Survival in Early-Stage Mycosis Fungoides. Clin Cancer Res. 2020 01 15; 26(2):408-418. PMID: 31636100; PMCID: PMC7122012.
    Citations: 6
    Fields: NeoNeoplasmsTranslation:HumansCells
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contact@catalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resources@hms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappt@hms.harvard.edu.
Larocca's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (113)
Explore
_
Co-Authors (42)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.